Influenza A/B & SARS-CoV-2 Multiplex Real-Time PCR Kit - Reliable Supply from China

Nanjing Liming Bio-products Co., Ltd. is proud to introduce our new SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit, designed to simplify the detection and differentiation of SARS-CoV-2 and Influenza A/B viruses in a single assay. This kit is specifically optimized for high sensitivity and specificity, allowing for early and accurate diagnosis of respiratory infections.

Utilizing advanced real-time polymerase chain reaction (PCR) technology, our multiplex kit can provide results within hours, significantly reducing turnaround time for patient diagnosis. The kit comes with all necessary reagents, including primers and probes, and is compatible with standard PCR equipment.

Reliable and efficient diagnosis is critical in the ongoing fight against infectious diseases, and our SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is poised to meet the challenge. As a leading manufacturer, supplier, and factory of molecular diagnostic products in China, Nanjing Liming Bio-products Co., Ltd. is committed to continuously delivering innovative and high-quality solutions to meet the needs of our customers.
  • Introducing the SARS-CoV-2 and Influenza A/B Multiplex Real-Time PCR Kit - a highly sensitive and specific diagnostic tool for the simultaneous detection of SARS-CoV-2 and Influenza A/B viruses. This kit utilizes real-time PCR technology for the qualitative detection of viral RNA from nasopharyngeal swab, bronchoalveolar lavage (BAL), and sputum specimens. The kit is designed to provide rapid and accurate results with high sensitivity and specificity, ensuring reliable diagnosis of SARS-CoV-2 and Influenza A/B infections. The multiplex assay is based on the detection of conserved regions of the viral genome, ensuring its efficiency even with emerging viral variants. The SARS-CoV-2 and Influenza A/B Multiplex Real-Time PCR Kit aims to streamline the diagnostic process, saving time and resources, and reducing the risk of cross-contamination between specimens. It has undergone rigorous validation and testing, demonstrating excellent performance in clinical evaluations, making it an ideal tool for clinical laboratories. The kit is easy to use with a straightforward protocol and requires minimal hands-on time. It includes all necessary reagents, controls, and standards for reliable and accurate results. The SARS-CoV-2 and Influenza A/B Multiplex Real-Time PCR Kit is a valuable asset for the diagnosis and surveillance of viral outbreaks, enabling prompt identification, and timely intervention.
  • Rapid antigen detection test for Neisseria gonorrhoeae in urine sediment shows promise in diagnosing gonococcal infection in males

    article based on the study. Researchers have evaluated a rapid antigen detection method with immunochromatographic assay for Neisseria gonorrhoeae in urine sediment to diagnose gonococcal infection i
  • Lab Now Accepting COVID-19 Specimens for Testing

    Nanjing Liming Bio-products Co., Ltd. has announced that its rapid test for COVID-19 has shown comparable performance when compared to other methods such as PCR or culture, which are known to be both
  • Diagnostic Efficacy of Two Rapid Tests for Detection of Respiratory Syncytial Virus Antigen in Children with Respiratory Symptoms

    Infectious diseases are a major public health concern worldwide, affecting both young and old populations. Respiratory syncytial virus (RSV) is one such infectious disease that is responsible for sign
  • New kit launched to detect and quantify SARS-CoV-2 in wastewater using digital PCR systems

    Nanjing Liming Bio-products Co., Ltd. has announced the development of a new rapid test for detecting sexually transmitted diseases (STDs). The company, which specializes in developing, manufacturing
  • ;